Cortex, Boston Scientific

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...
Shares of Boston Scientific Corp. BSX inched 0.97% higher to $85.54 Tuesday, on what proved to be an all-around positive ...
Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial ...
Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.
Boston Scientific (NYSE:BSX) today announced that a study of its Acurate neo2 aortic valve system missed its primary endpoint ...
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...
Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...